2 months ago
RVMD
AnalystsMichael SchmidtMichael Schmidt's Stock Forecasts
AnalystsMichael Schmidt
Analyst Ranking
Top 25%
#1185 out of 4800 analysts
Average Return
+5.56%
Win Rate
47%27 out of 58
Risk vs Reward
Poor
Good
Michael Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +235.60% | $26.18 | $87.86 | 2020-04-22 - 2020-10-22 | Strong Buy |
Mirati Therapeutics IncMRTX | +182.05% | $13.20 | $37.23 | 2017-11-13 - 2018-11-14 | Buy |
Forty Seven IncFTSV | +165.60% | $35.96 | $95.51 | 2019-12-10 - 2020-04-06 | Strong Buy |
Verastem IncVSTM | +97.99% | $2.99 | $5.92 | 2024-09-29 - 2025-01-24 | Strong Buy |
Mirati Therapeutics IncMRTX | +87.42% | $31.32 | $58.70 | 2023-07-23 - 2024-01-22 | Strong Buy |
Michael Schmidt Analyst Color
Get additional color on Michael Schmidt's coverage of popular stocks
3 months ago
EXEL
a year ago
EXEL
2 years ago
SNDX
2 years ago
ONC
3 years ago
ACET
Michael Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $78.00 | +115.71% | Maintains | 17 days ago |
Exelixis IncEXEL | 5 | Strong Buy | $42.00 | +29.71% | Maintains | 18 days ago |
Adc Therapeutics SaADCT | 2 | Strong Buy | $10.00 | +464.97% | Reiterates | a month ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $20.00 | +341.50% | Reiterates | 2 months ago |
Merus NvMRUS | 2 | Strong Buy | $111.00 | +168.77% | Maintains | 2 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $87.00 | +112.25% | Maintains | 2 months ago |
Zentalis Pharmaceuticals IncZNTL | 3 | Strong Buy | $8.00 | +260.36% | Maintains | 2 months ago |
Adaptimmune Therapeutics PLCADAP | 2 | Strong Buy | $3.00 | +406.76% | Maintains | 2 months ago |
Verastem IncVSTM | 1 | Strong Buy | $13.00 | +119.59% | Initiates Coverage On | 4 months ago |
Incyte CorpINCY | 3 | Strong Buy | $92.00 | +26.74% | Maintains | 4 months ago |
Nanobiotix SaNBTX | 1 | Strong Buy | $12.00 | +247.83% | Initiates Coverage On | 5 months ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $92.00 | +178.79% | Reiterates | 9 months ago |
Immunome IncIMNM | 1 | Strong Buy | $35.00 | +251.76% | Initiates Coverage On | 9 months ago |
Mersana Therapeutics IncMRSN | 2 | Strong Buy | $7.00 | +988.65% | Upgrades | a year ago |
Beigene LtdONC | 4 | Strong Buy | $345.00 | +55.35% | Maintains | a year ago |
Immunogen IncIMGN | 1 | Hold | $31.00 | N/A | Downgrades | a year ago |
Xencor IncXNCR | 2 | Strong Buy | $34.00 | N/A | Maintains | a year ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $60.00 | N/A | Maintains | 2 years ago |
Adicet Bio IncACET | 3 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $82.00 | N/A | Maintains | 2 years ago |
Oric Pharmaceuticals IncORIC | 2 | Hold | $15.00 | N/A | Downgrades | 2 years ago |
Seagen IncSGEN | 3 | Strong Buy | $170.00 | N/A | Reiterates | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $22.00 | N/A | Upgrades | 2 years ago |
Neurogene IncNGNE | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Rubius Therapeutics IncRUBY | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 3 years ago |
Erasca IncERAS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Cellectis SaCLLS | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 4 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $39.00 | N/A | Maintains | 5 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Forty Seven IncFTSV | 1 | Strong Buy | $48.00 | N/A | Maintains | 5 years ago |
Bluebird Bio IncBLUE | 4 | Hold | N/A | N/A | Downgrades | 6 years ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $80.00 | N/A | Upgrades | 6 years ago |
Clovis Oncology IncCLVSQ | 2 | Hold | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $24.00 | N/A | Reinstates | 6 years ago |
Array Technologies IncARRY | 1 | Buy | $20.00 | N/A | Maintains | 7 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | $87.00 | N/A | Downgrades | 7 years ago |
Arbutus Biopharma CorpABUS | 1 | Hold | $5.50 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.